ARTICLE | Company News
Affymetrix, Cytox deal
August 24, 2015 7:00 AM UTC
Cytox and Affymetrix partnered to develop and commercialize a blood-based genetic assay for Alzheimer’s disease (AD) and mild cognitive impairment (MCI). The collaboration will combine Affymetrix’s Ax...